In an April 2 letter, a group of over 200 stakeholders urged the Drug Enforcement Administration (DEA) to release a revised proposed rule that would “permit and regulate the prescribing of controlled substances through…
Continue Reading
With current pandemic-era flexibilities for telemedicine set to expire at the end of 2024, several telehealth groups and major health systems are calling on the U.S. Drug Enforcement Administration to work faster in crafting…
Continue Reading
By Anuja Vaidya
March 06, 2024 – The United States Attorney’s Office for the Central District of California has sentenced a former physician to 37 months in federal prison for illegally prescribing medications, including opioid-based drugs,…
Continue Reading
Two bills in U.S. Congress this year are expected to boost e-prescriptions. This article explains the complexities that makes it so hard to implement electronic prescribing for controlled substances (EPCS), summarizes the intended impacts…
Continue Reading
Top News
A district attorney in New York charges a 21 year-old Florida man with stealing the prescribing credentials of hundreds of doctors, which he used to fill and sell tens of thousands of prescriptions…
Continue Reading
When the Drug Enforcement Administration (DEA) released its proposed rule that would remove some of the Covid-19 telehealth flexibilities for the prescribing of controlled substances, it caused an uproar from telehealth companies and advocates….
Continue Reading
MIDAS Healthcare Solutions, Inc., the leading developer of technology-driven solutions to promote the safe use, storage, return, and disposal of controlled substances and other dangerous medications in hospitals and other healthcare institutions, announced today…
Continue Reading
The DEA has extended remote prescribing of controlled substances until the end of 2024, granting a second extension to consider new regulations. This move eliminates the proposed rule requiring in-person visits for controlled medication…
Continue Reading
At the Drug Enforcement Agency Drug Diversion Division listening sessions earlier this month, DEA Administrator Anne Milgram said the agency would hold a second comment period on its March NPRM in the months ahead.WHY…
Continue Reading
To ensure compliance with Electronic Prescribing of Controlled Substances (EPCS), healthcare providers can turn to IdenTrust’s one-stop solution for streamlined identity-proofing and multi-factor authentication. With the rise of e-prescribing legislation and the opioid crisis,…
Continue Reading
